Aeon Biopharma Inc (AEON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Operating Expenses | 462 | 2,322 | 4,016 | -153,473 | 74,150 |
| Operating Income | -462 | -2,322 | -4,016 | 153,473 | -74,150 |
| Other Income | 9,557 | 4,404 | -2,155 | 10,639 | -43,868 |
| Pre-tax Income | 9,095 | 2,082 | -6,171 | 164,112 | -118,018 |
| Net Income Continuous | 9,095 | 2,082 | -6,171 | 164,112 | -118,018 |
| Net Income | $9,095 | $2,082 | $-6,171 | $164,112 | $-118,018 |
| EPS Basic Total Ops | 2.28 | 12.85 | -11.24 | 304.00 | -227.87 |
| EPS Basic Continuous Ops | 2.28 | 12.95 | -11.24 | 303.91 | -227.83 |
| EPS Diluted Total Ops | 2.28 | 8.04 | -11.24 | 304.00 | -227.87 |
| EPS Diluted Continuous Ops | 2.28 | 8.09 | -11.24 | 303.91 | -227.83 |
| EPS Diluted Before Non-Recurring Items | -0.09 | 3.75 | -11.51 | -11.51 | N/A |
| EBITDA(a) | $-443 | $-2,299 | $-3,991 | $153,497 | $-74,125 |